Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients

被引：0
|
作者：
P Aragona
A Stilo
F Ferreri
M Mobrici
机构：
[1] Section of Ophthalmology,Department of Surgical Science
[2] University of Messina,undefined
来源：
Eye | 2005年 / 19卷
关键词：
indomethacin; diclofenac; corneal sensitivity; corneal epithelial defects; Sjögren's syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：535 / 539
页数：4
相关论文
共 50 条
  • [21] Rational Drug Therapy Recommendations for the Treatment of Patients with Sjögren's Syndrome
    Peter Oxholm
    Jan U. Prause
    Morten Schiødt
    Drugs, 1998, 56 : 345 - 353
  • [22] Diagnose und Therapie des Sjögren-SyndromsDiagnosis and treatment of Sjögren’s syndrome
    Josef Hermann
    Jutta Horwath-Winter
    Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen, 2019, 26 (2) : 50 - 56
  • [23] Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: A preliminary study
    Streckfus C.
    Bigler L.
    Navazesh M.
    Al-Hashimi I.
    Clinical Oral Investigations, 2001, 5 (2) : 133 - 135
  • [24] Primary Sjögren's syndrome without ocular manifestation: a case report
    Mohammad, Aya
    Btrush, Sana
    Makhlouf, Zeina
    Alkasem, Abeer
    Abdoh, Hoda
    Kudsi, Maysoun
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (08): : 4816 - 4819
  • [25] The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren’s syndrome
    Hülya Devecı
    Senol Kobak
    International Ophthalmology, 2014, 34 : 1043 - 1048
  • [26] Meibomian gland dropout in Sjögren’s syndrome and non-Sjögren’s dry eye patients
    Siwen Zang
    Ying Cui
    Yang Cui
    Wenlei Fei
    Eye, 2018, 32 : 1681 - 1687
  • [27] Update on Sjögren's syndrome Diagnostics, treatment, and challenges
    Zehrfeld, Nadine
    Witte, Torsten
    Ernst, Diana
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (03): : 217 - 228
  • [28] The Future of Biologic Agents in the Treatment of Sjögren’s Syndrome
    Jiska M. Meijer
    Justin Pijpe
    Hendrika Bootsma
    Arjan Vissink
    Cees G. M. Kallenberg
    Clinical Reviews in Allergy & Immunology, 2007, 32 : 292 - 297
  • [29] Endoplasmic reticulum stress in the salivary glands of patients with primary Sjögren's syndrome, associated Sjögren's syndrome, and non-Sjögren's sicca syndrome: a comparative analysis and the influence of chloroquine
    Cavalcanti, Graziela Vieira
    de Oliveira, Fabiola Reis
    Bannitz, Rafael Ferraz
    de Paula, Natalia Aparecida
    Motta, Ana Carolina Fragoso
    Rocha, Eduardo Melani
    Chiorini, John
    Ricz, Hilton Marcos Alves
    Garcia, Denny Marcos
    Foss-Freitas, Maria Cristina
    de Freitas, Luiz Carlos Conti
    ADVANCES IN RHEUMATOLOGY, 2025, 65 (01):
  • [30] ANS function is impaired in patients with Sjögren's syndrome
    Nature Clinical Practice Rheumatology, 2007, 3 (12): : 689 - 689
12345